Basidiobolomycosis is a rare fungal infection that usually affects the skin and soft tissue. People with basidiobolomycosis often notice a firm, painless or mildly tender swelling that grows slowly. It usually develops over weeks to months and can affect children and adults in tropical and subtropical areas. Mortality is low with timely diagnosis, but severe disease can occur if the infection spreads to deeper tissues or the gut. Treatment typically includes months of antifungal medicine and surgery when needed.
Overview
BasidiobolomycosisSymptoms
Basidiobolomycosis usually causes a slowly enlarging, firm swelling under the skin on the buttocks, thighs, or trunk; it’s often painless but can feel tender or itchy. Gastrointestinal disease can bring abdominal pain, fever, weight loss, constipation, or a belly mass.
Outlook and prognosis
Most people with basidiobolomycosis do well with timely, adequate antifungal treatment and, when needed, limited surgery. Recovery can take weeks to months, and follow‑up helps prevent relapse. Severe illness is uncommon but more likely with delayed diagnosis or widespread infection.
Causes and risk factors
Basidiobolomycosis results from Basidiobolus fungi in soil, decaying vegetation, and animal droppings, entering through minor skin injuries or ingestion. Risks include living or traveling in tropical/subtropical climates, outdoor or barefoot exposure, and childhood or adolescent age; immune compromise isn’t required.
Genetic influences
Genetics play little to no role in basidiobolomycosis. It’s primarily an environmental infection from a soil- and plant-associated fungus. Rare immune system variants may affect severity or recovery, but heredity doesn’t meaningfully change risk for most people.
Diagnosis
Doctors suspect basidiobolomycosis from a slow-growing, firm swelling and imaging. The diagnosis is confirmed by taking a small tissue sample (biopsy) for fungal stain and culture. Additional tests help rule out other causes and map disease spread.
Treatment and drugs
Treatment for basidiobolomycosis centers on long courses of antifungal medicines, commonly itraconazole or voriconazole. Surgeons may remove affected tissue if a lump is large, not healing, or blocking the bowel. Regular follow‑up checks help confirm the infection is clearing.
Symptoms
Basidiobolomycosis can show up as a slow-growing swelling under the skin or as gut symptoms that develop gradually. Early symptoms of Basidiobolomycosis are often subtle, like a firm, painless lump that seems to spread over weeks or mild, crampy belly discomfort. Symptoms vary from person to person and can change over time. Some only notice a firm lump, while others develop abdominal pain, bowel changes, or low-grade fever.
A firm, rubbery lump under the skin slowly enlarges, often on an arm, leg, buttock, or trunk. The area may feel tight or heavy rather than sore. You might notice small changes at first.
The skin over the lump can look slightly reddish or darker and feel warm to the touch. In Basidiobolomycosis, open sores are uncommon early on.
While usually painless, the area can feel mildly tender or itchy. Discomfort may be more noticeable with pressure or movement.
Swelling next to a joint can limit how far it moves or make it harder to bend. What once felt effortless can start to require more energy or focus.
How people usually first notice Basidiobolomycosis?
Basidiobolomycosis is usually first noticed as a slowly growing, firm swelling under the skin—often on the buttocks, thighs, trunk, or arms—that feels rubbery, is not very painful, and doesn’t improve with usual antibiotics. People may recall minor skin trauma or insect bites, and doctors often spot warm, thickened skin with overlying redness that progresses over weeks to months, sometimes with nearby swollen lymph nodes. In children and young adults living in tropical or subtropical areas, this pattern—persistent, painless swelling that keeps enlarging—tends to be the first signs of basidiobolomycosis.
Types of Basidiobolomycosis
Basidiobolomycosis is a rare fungal infection that typically affects the skin and tissue just beneath it and, less commonly, the gastrointestinal (GI) tract. Because it can look like other conditions, early symptoms of basidiobolomycosis are often mistaken for infections or even tumors. People may notice different sets of symptoms depending on their situation. Broadly, symptoms are grouped into cutaneous (skin/soft tissue) and gastrointestinal forms, which differ in where they appear and how they feel day to day.
Cutaneous form
Usually shows up as a firm, painless or mildly tender swelling under the skin, often on the limbs, trunk, or buttocks. The area may feel rubbery and slowly enlarge over weeks to months. Skin can look normal at first or become slightly red or warm.
Gastrointestinal form
Tends to cause belly pain, a feeling of fullness, and unexplained weight loss, sometimes with low-grade fever. People may have constipation or a mass that can be felt in the abdomen, and blood tests often show high eosinophils. This form can mimic inflammatory bowel disease or cancer, so diagnosis may take longer.
What genetics can tell you about symptoms
Some people with immune gene differences, like variants affecting neutrophil or T‑cell function, are more likely to develop deeper skin or gastrointestinal basidiobolomycosis with fever, pain, or swelling. These changes can blunt early fungus‑clearing responses, letting infections spread and worsen.
Causes and risk factors
Basidiobolomycosis occurs after exposure to a Basidiobolus fungus in soil, decaying plants, or animal droppings. The fungus can enter through small skin breaks during gardening or play, or by eating food contaminated from the ground. Doctors distinguish between risk factors you can change and those you can’t. Warmer, humid climates, younger age, and close contact with reptiles or amphibians can raise baseline risk, and it is not spread from person to person. A weak immune system and frequent barefoot contact with soil are risk factors for basidiobolomycosis, while no specific inherited risks are known.
Environmental and biological risk factors
Basidiobolomycosis is a rare fungal infection picked up from the environment, usually affecting the skin or, less often, the gut. When learning about early symptoms of basidiobolomycosis, it helps to know who faces higher exposure and susceptibility. Doctors often group risks into internal (biological) and external (environmental). Below are factors that can raise the chance of contact or make it easier for this fungus to take hold.
The Basidiobolus fungus thrives in tropical and subtropical settings with heat and moisture. Living in or traveling to these regions can increase exposure to basidiobolomycosis.
Contact with soil, compost, or decaying leaves can carry fungal material. Tiny skin breaks can let it enter and start an infection.
Feces from geckos, lizards, or amphibians can contaminate soil or surfaces. Close household exposure to these animals may raise environmental contact with the fungus.
Cuts, scrapes, or punctures create a doorway for the fungus. Even small, unnoticed wounds can allow basidiobolomycosis to develop.
Genetic risk factors
Researchers have not identified a single gene that causes basidiobolomycosis. Most people are otherwise healthy, yet rare, inborn immune differences can increase susceptibility to uncommon fungal infections. Risk is not destiny—it varies widely between individuals. Scientists continue to study genetic risk factors for basidiobolomycosis to clarify who might be more vulnerable.
No single-gene cause: There is no confirmed single-gene cause for basidiobolomycosis. Most people diagnosed do not have a known inherited disorder. Genetic testing is usually guided by the clinical picture rather than done routinely.
Inborn immune defects: Some people are born with immune system differences that weaken antifungal defenses. These rare conditions can make uncommon infections more likely. Carrying a genetic change doesn’t guarantee the condition will appear.
CARD9 pathway variants: CARD9 and related genes help immune cells signal and coordinate attacks against fungi. Inherited changes in this pathway are a well-established cause of severe fungal disease in some families. When basidiobolomycosis is unusually aggressive or recurrent, doctors may consider testing for this.
White cell killing defects: Genes that affect how certain white blood cells engulf and kill fungi can increase vulnerability. Examples include rare disorders that limit the cells’ oxidative burst, which is key for clearing molds and yeasts. Basidiobolomycosis can still occur in people with normal immunity, so these defects are not required for it.
IL-17 pathway changes: Alterations in a pathway called IL-17 can reduce barrier defenses at skin and gut surfaces. They are best known for chronic yeast infections but may also lower protection against other fungi. Their role in basidiobolomycosis is not fully defined.
Family history clues: A family history of severe or unusual fungal infections can suggest an inherited susceptibility. If several relatives have had such infections, a clinical genetics evaluation may be reasonable.
Lifestyle risk factors
Lifestyle choices can influence the chance of developing or worsening this infection and how quickly it’s identified and treated. Practical habits around skin protection, wound care, and food handling matter most. In particular, lifestyle risk factors for Basidiobolomycosis relate to behaviors that create skin breaks, suppress local immunity, or introduce contamination to skin or food.
Going barefoot or wearing minimal protection outdoors increases small skin breaks that allow infection to enter. Protective footwear and clothing lower skin injury and contamination risk.
Leaving scratches, bites, or cuts uncleaned and uncovered can let infection take hold. Prompt washing with soap and water and covering until healed reduces risk.
Eating unwashed raw vegetables or handling garden produce with bare hands can transfer organisms to the gut or skin. Thorough washing and safe kitchen hygiene may reduce gastrointestinal involvement.
Gardening without gloves and kneeling on bare ground raises chances of abrasions and inoculation. Using sturdy gloves and barrier pads helps protect skin.
Risk prevention
Basidiobolomycosis is a rare fungal infection linked to soil and decaying plant matter, especially in warm, humid areas. You can lower risk by protecting your skin, keeping wounds clean, and using safe food and water practices during outdoor work or travel. Prevention is about lowering risk, not eliminating it completely. Getting prompt care for unexplained skin lumps or belly symptoms after exposure may help avoid complications.
Wear closed-toe shoes and gloves when gardening, farming, or handling decaying plants. Long trousers and sleeves add a barrier between your skin and contaminated soil.
Rinse cuts, scrapes, or punctures with clean running water and mild soap, then cover with a clean bandage. This reduces the chance that fungi in soil enter through broken skin.
Wash fruits and vegetables well, peel when possible, and cook thoroughly if unsure about cleanliness. Use safe drinking water, especially when traveling in tropical or subtropical regions where basidiobolomycosis has been reported.
Wash hands and forearms after yardwork or handling compost. Keep nails trimmed and clean so soil does not stay trapped against the skin.
Transmission
Basidiobolomycosis is caught from the environment, not from other people. The fungus lives in soil and decaying plant matter (and sometimes animal droppings), and can enter through tiny cuts, scrapes, or insect bites on the skin; rarely, swallowing contaminated material can lead to gastrointestinal infection. This explains how Basidiobolomycosis is transmitted in tropical and subtropical areas where people have frequent contact with soil and vegetation.
Basidiobolomycosis is not considered contagious between people and does not spread through casual contact, coughing, sex, or shared items. Its overall infectiousness is low because everyday exposures rarely lead to disease, and most healthy people who contact the fungus do not become sick.
When to test your genes
Basidiobolomycosis is an acquired fungal infection; genetic testing isn’t used for diagnosis or routine care. Test your genes only if you have a strong family history of immune deficiencies, unusually severe or recurrent infections, or clinician concern for an inherited immune disorder. Otherwise, focus on prompt clinical evaluation and appropriate antifungal treatment.
Diagnosis
Basidiobolomycosis is usually picked up when slow-growing skin swellings or unexplained belly pain prompt a closer look. Doctors usually begin with your story and a physical exam, then add tests to sort infection from other causes. In clinics that see this infection more often, providers think about the diagnosis of basidiobolomycosis when swelling is firm, painless, and doesn’t respond to routine antibiotics. Imaging and tissue sampling often provide the clearest answers.
Clinicians ask about symptom timing, travel, outdoor exposure, and prior antibiotics. They check for firm, painless swellings under the skin or signs of abdominal tenderness and masses.
Basic labs may show inflammation and sometimes higher-than-usual eosinophils, a type of white blood cell. These results are not specific but can support suspicion when combined with other findings.
Ultrasound or CT can outline the size and location of soft-tissue or bowel masses. Imaging helps guide where to sample tissue and can differentiate infection from tumors or inflammatory diseases.
A small piece of the swollen area or bowel mass is examined under a microscope. Pathology can show features consistent with a fungal infection and helps steer next steps.
Stages of Basidiobolomycosis
Basidiobolomycosis does not have defined progression stages. It can affect the skin or the gastrointestinal tract, and how it changes over time depends on where it is and how quickly it grows, so care teams judge severity by location and extent rather than a formal stage. Doctors usually start with a conversation about your symptoms—such as early symptoms of basidiobolomycosis like a firm, painless skin lump or ongoing belly pain—then perform an exam, imaging, and take a small tissue sample (biopsy) to confirm the fungus. Progress is usually monitored by whether symptoms settle and by follow-up exams or scans.
Outlook and prognosis
Looking ahead can feel daunting, but most people with basidiobolomycosis do well when it’s recognized and treated early. This infection typically grows slowly in the skin and soft tissue, and with the right antifungal medication—and sometimes surgery to remove a firm mass—recovery is the norm. Death is rare in skin-limited disease. The main risks come when the fungus involves the bowel or spreads deeper, which can happen if diagnosis is delayed or if someone has other health challenges that complicate care.
Doctors call this the prognosis—a medical word for likely outcomes. For skin or subcutaneous basidiobolomycosis, treatment often lasts several months, and the swelling and tenderness usually fade over weeks. In gastrointestinal basidiobolomycosis, people often need a combination of surgery and long courses of antifungals; outcomes are still good when care starts early, but serious complications like bowel blockage or perforation can occur.
Everyone’s journey looks a little different. Early symptoms of basidiobolomycosis—like a slowly enlarging, painless lump that feels rubbery—can be easy to miss, so timely evaluation matters. After successful treatment, most people return to normal routines, though follow-up visits and imaging help catch any signs of relapse. Talk with your doctor about what your personal outlook might look like, including how long to stay on medication, what warning signs to watch for, and how to pace back into work, school, or activity.
Long-term effects
Basidiobolomycosis is rare but usually treatable, and the long-term picture depends on where the infection took hold—skin and soft tissue versus the gut. Long-term effects vary widely and often reflect how extensive the infection was and how early it was treated. Many people do well after antifungal therapy, though some may live with lasting changes in the affected area. Recovery can also be shaped by any surgery that was needed and by how the body tolerated months of antifungal medication.
After subcutaneous infection, some are left with firm scars under the skin. This can limit stretch or motion near joints. Physical therapy may gradually improve flexibility.
Lymphatic channels can stay damaged after basidiobolomycosis in an arm or leg. Ongoing swelling may cause heaviness, discomfort, or skin changes. Compression and elevation can help symptoms.
When the gut is involved, healing can leave strictures or adhesions. These may lead to cramps, bloating, or bowel blockage episodes. Some people need procedures or surgery if narrowing worsens.
Long infections and gut involvement can cause weight loss and low nutrients. Recovery often brings weight gain back, but some need longer nutrition support. Blood tests may track iron or vitamin levels.
How is it to live with Basidiobolomycosis?
Living with basidiobolomycosis often starts with a stubborn, slowly enlarging swelling under the skin that feels firm and mildly tender, usually on the limb, trunk, or buttock. Day to day, people may deal with discomfort, limited movement near the affected area, and the worry of a lingering infection that needs months of antifungal treatment and regular check-ins. For families and close friends, it can mean helping with wound care if surgery is needed, supporting clinic visits, and encouraging treatment adherence while staying calm about a condition that is not contagious through casual contact. With steady medical care and patience, most regain comfort and routine, though healing can be gradual.
Treatment and drugs
Basidiobolomycosis is treated primarily with antifungal medication taken for several months, often itraconazole or voriconazole, and treatment usually continues until scans and exams show the infection has fully cleared. Doctors sometimes recommend surgical removal of infected tissue, especially if a lump is blocking the bowel or the diagnosis is uncertain, but surgery is typically paired with ongoing antifungal therapy to prevent relapse. A doctor may adjust your dose to balance benefits and side effects, with regular blood tests to check liver function and drug levels. Alongside medical treatment, lifestyle choices play a role, such as taking medicines with food if advised, staying hydrated, and promptly reporting new symptoms like abdominal pain, fever, or yellowing of the eyes. Not every treatment works the same way for every person, so close follow‑up with infectious disease and surgical teams helps tailor care and reduce the chance of the infection coming back.
Non-drug treatment
Basidiobolomycosis often affects skin and soft tissue, and the day-to-day impact can include swelling, firm lumps, and discomfort that makes moving or sleeping harder. Alongside medicines, non-drug therapies can reduce pressure, protect healing tissue, and support recovery. Surgery and careful wound care are commonly used to control the infection locally and ease symptoms. Plans vary by the site and extent of disease, and your team will tailor steps to your needs.
Removing the main infected lump can quickly reduce pressure and pain. Surgeons often take a small margin and send tissue for testing to confirm basidiobolomycosis and check edges.
If pus builds up, a small cut or image-guided drainage can relieve pain and lower local infection burden. This also provides a sample to confirm the diagnosis and guide the overall plan.
Gentle cleaning, moist dressings, and protection from friction help wounds close and lower the chance of skin breakdown. Regular checks can catch signs that basidiobolomycosis is not improving or that new areas need attention.
Keeping the affected limb raised can reduce swelling and throbbing. Short, gentle movement between rests helps prevent stiffness without stressing healing tissue.
Your genes may have an impact on how drugs work for you
Some medicines for basidiobolomycosis are processed by liver enzymes that vary by gene, which can change how quickly a drug is cleared and how strong its effect feels. In practice, clinicians may adjust dose or choose alternatives if genetics or side effects suggest poor fit.
Pharmacological treatments
Basidiobolomycosis is usually treated with antifungal medicines taken for several months to fully clear the infection and prevent relapse. First-line medications are those doctors usually try first, based on how well they work and their safety. Treating soon after early symptoms of basidiobolomycosis appear can shorten recovery and reduce complications. Your care team will tailor the drug and duration to your age, other medicines, and how widespread the infection is.
Often the first-choice oral antifungal. Taken daily for several months until skin findings and lab markers improve. Requires liver test monitoring and checking for drug interactions.
A long-used option that can be very effective for skin-limited disease. Doses are increased gradually and continued for months after recovery signs. Can cause stomach upset or affect the thyroid and is usually avoided in pregnancy.
An alternative or add-on if itraconazole is not suitable or not enough. Taken by mouth for an extended course until the infection clears. Liver monitoring and interaction review are recommended.
Options for difficult or relapsing cases when first-line drugs fail. Doctors watch for side effects like vision changes (with voriconazole) and check for interactions and cost considerations. Courses may be prolonged.
Genetic influences
Most people develop basidiobolomycosis after contact with the environment—such as soil or decaying plants—rather than because of something inherited. Genetics is only one piece of the puzzle, but it doesn’t appear to be the main driver here. Family clusters are uncommon, and there’s no evidence of a predictable inherited pattern. Researchers are exploring whether natural differences in the immune system—how the body recognizes and clears fungi—might make some people more susceptible. Rare, inherited immune conditions can raise the risk of serious fungal infections in general, yet a direct, proven link to basidiobolomycosis is still lacking. If you’re wondering whether basidiobolomycosis is hereditary, current evidence suggests it is not; reducing exposure risk and getting timely care remain the priorities.
Is Basidiobolomycosis genetic?
Genetics play little to no role in basidiobolomycosis. It’s primarily an environmental infection from a soil- and plant-associated fungus. Rare immune system variants may affect severity or recovery, but heredity doesn’t meaningfully change risk for most people.
Pharmacogenetics—how genetics influence drug effects
Genetic differences can shape how well certain antifungal medicines work for basidiobolomycosis and whether side effects appear. Genes can influence how quickly you process azole antifungals, such as itraconazole and voriconazole. For voriconazole in particular, changes in a liver enzyme called CYP2C19 can lead to very high drug levels (raising the chance of liver irritation or visual side effects) or very low levels (raising the chance the medicine won’t work). When that happens, your care team may adjust the dose, monitor blood levels closely, or choose a different antifungal, such as posaconazole, that is less affected by this gene. These drug–gene insights don’t replace standard care for the treatment of basidiobolomycosis—surgery, drug interactions, and liver and kidney health still guide decisions—but they can help reduce trial and error. If azoles have caused side effects or didn’t help in the past, your team may consider pharmacogenetic testing or therapeutic drug monitoring to tailor therapy and support safer, more effective care.
Interactions with other conditions
Basidiobolomycosis can blur the picture when other gut or skin conditions are present. Early symptoms of basidiobolomycosis in the bowel—abdominal pain, a mass, constipation, or weight loss—often resemble inflammatory bowel disease or even colorectal cancer, so people may be treated for the wrong problem at first. To understand overall health, it’s useful to see how conditions overlap. For example, allergies or parasitic infections that raise eosinophil counts can make test results look similar to this fungal illness, while steroid treatment for presumed colitis or asthma can suppress immunity and allow the infection to spread more quickly. In the skin, swelling and firm lumps may be mistaken for bacterial cellulitis or soft-tissue tumors, which can delay the right care. Although basidiobolomycosis usually affects otherwise healthy people, those on long-term steroids or other immune-suppressing medicines for another disease may face a higher risk of severe infection, so coordinated care and careful reassessment are important if symptoms don’t improve as expected.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described slow-growing, firm swellings under the skin that didn’t act like typical infections. In warm, rural regions, families recalled a child developing a painless lump on the thigh after playing outdoors, or an adult noticing a firm plaque on the trunk that seemed to spread gradually. These accounts hinted at a quiet, unusual infection we now recognize as basidiobolomycosis.
First described in the medical literature as a distinct skin and soft-tissue infection in the mid-20th century, basidiobolomycosis was initially linked to minor skin breaks and everyday exposures in tropical and subtropical climates. Early reports came from parts of Africa, the Middle East, and South Asia, where clinicians noticed that the condition often involved the limbs or trunk, progressed slowly, and rarely caused fever. At the time, it was often mistaken for bacterial infections, deep fungal diseases with different causes, or even certain tumors, which delayed the right treatment.
Over time, descriptions became more precise as doctors connected the illness to Basidiobolus species, fungi found in soil and decaying plants. Tissue samples examined under the microscope revealed characteristic patterns that helped separate basidiobolomycosis from look-alike conditions. With better laboratory methods and growing clinical experience, clinicians learned that many people with basidiobolomycosis improved with the right antifungal medications and, when necessary, limited surgery.
In recent decades, awareness has grown beyond the regions where it was first recognized. Occasional cases in new geographic areas taught clinicians to consider basidiobolomycosis when evaluating slowly enlarging, firm skin or soft-tissue lesions that don’t respond to antibiotics. Reports also broadened the picture to include rare involvement of deeper tissues, including the gastrointestinal tract, while confirming that skin and soft tissue remain the most typical sites.
Advances in diagnostics—culture techniques and later DNA-based tools—made it easier to identify Basidiobolus directly from tissue. This reduced misdiagnosis and supported targeted treatment. As case series accumulated, medical teams refined approaches to care, emphasizing early recognition, confirmation with biopsy, and antifungal therapy tailored to local practice and drug availability.
Today’s understanding of basidiobolomycosis reflects many small steps taken by clinicians and researchers across several continents. Historical differences highlight why careful examination and testing matter for conditions that look similar on the surface. Knowing the condition’s history helps explain current recommendations: act early when a chronic, painless swelling doesn’t fit the usual pattern, confirm the diagnosis with appropriate samples, and start effective antifungal treatment to prevent complications.